Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of DBPR108 plus metformin in type 2 diabetes mellitus
ChiCTR2000032566Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prusogliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: HbA1c. Planned start May 2020; status: not yet recruiting.
02
Drugs
prusogliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000032566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032566.